Crossmark

Synthesizing regulatory guidance for demonstrating preclinical efficacy and translating promising cell therapies to early phase clinical trials: a scoping review

Crossref DOI link: https://doi.org/10.1186/s12916-024-03690-8

Published Online: 2024-10-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jeffers, Matthew S.

Xi, Cheng En

Bapuji, Raj

Wotherspoon, Hannah

Kimmelman, Jonathan

Bedford, Patrick

McIsaac, Daniel I.

Lalu, Manoj M. https://orcid.org/0000-0002-0322-382X
Fergusson, Dean A. https://orcid.org/0000-0002-3389-2485
License Information

Text and Data Mining valid from 2024-10-23

Version of Record valid from 2024-10-23
More Information

Article History

Received: 22 December 2023

Accepted: 8 October 2024

First Online: 23 October 2024

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below